Bicara Therapeutics Inc. (BCAX) Stock Price, News, Quote & History ...

Find the latest Bicara Therapeutics Inc. (BCAX) stock quote, history, news and other vital information to help you with your stock trading and investing.

$13.46
OFF

Bicara Therapeutics (NASDAQ:BCAX) Hits New 52-Week Low

2 weeks from now

3 days ago · Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $13.46 and last …

marketbeat.com

59%
OFF

Bicara Therapeutics. Common Stock Stock Price Forecast. Should …

2 weeks from now

Dec 31, 2024 · The Bicara Therapeutics Inc. Common Stock stock price gained 1.59% on the last trading day (Thursday, 19th Dec 2024), rising from $16.34 to $16.60. During the last trading …

stockinvest.us

FAQs about Bicara Therapeutics Inc. (BCAX) Stock Price, News, Quote & History ... Coupon?

Will Bicara Therapeutics Inc (bcax) go public?

Bicara Therapeutics has filed to go public with an IPO on the NASDAQ. Get a real-time Bicara Therapeutics Inc. (BCAX) stock price quote with breaking news, financials, statistics, charts and more. ...

What does bcax stand for?

Find the latest Bicara Therapeutics Inc. (BCAX) stock quote, history, news and other vital information to help you with your stock trading and investing. ...

How much is Bicara Therapeutics worth?

Bicara Therapeutics said on Friday it is seeking a valuation of up to $828 million in its initial public offering in the United States, as new listings continue to flock the markets. Bicara Therapeutics aims to raise $200 million through an IPO to advance its promising bifunctional antibody treatment for head and neck cancers. ...

Does Bicara therapeutics have an IPO?

Bicara Therapeutics, a TPG-backed biopharmaceutical company developing a therapy targeting tumors, said on Wednesday it plans to raise up to $265 million through an upsized initial public offering (IP... Two small IPOs and two SPACs debuted this past week - Pheton Holdings, Powell Max, Vine Hill Capital, and Andretti Acquisition II, respectively. ...

Where is bcax based?

The company was incorporated in 2018 and is based in Boston, Massachusetts. Trailing total returns as of 12/31/2024, which may include dividends or other distributions. Benchmark is S&P 500 Select to analyze similar companies using key performance metrics; select up to 4 stocks. BCAX does not have Company Insights ...

Why did Bicara Therapeutics stock surge 46% on Friday?

Shares of Bicara Therapeutics surged nearly 46% in their market debut on Friday, signaling strong investor interest for the TPG-backed cancer therapy developer. ...